473 related articles for article (PubMed ID: 16701972)
1. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.
Tafaghodi M; Sajadi Tabassi SA; Jaafari MR
Int J Pharm; 2006 Aug; 319(1-2):37-43. PubMed ID: 16701972
[TBL] [Abstract][Full Text] [Related]
2. Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN.
Tafaghodi M; Jaafari MR; Sajadi Tabassi SA
Eur J Pharm Biopharm; 2006 Oct; 64(2):138-45. PubMed ID: 16797952
[TBL] [Abstract][Full Text] [Related]
3. Induction of high antitoxin titers against tetanus toxoid in rabbits by intranasal immunization with dextran microspheres.
Sajadi Tabassi SA; Tafaghodi M; Jaafari MR
Int J Pharm; 2008 Aug; 360(1-2):12-7. PubMed ID: 18538516
[TBL] [Abstract][Full Text] [Related]
4. Preparation and in vivo study of dry powder microspheres for nasal immunization.
Tafaghodi M; Rastegar S
J Drug Target; 2010 Apr; 18(3):235-42. PubMed ID: 19929307
[TBL] [Abstract][Full Text] [Related]
5. Nasal immunization studies by cationic, fusogenic and cationic-fusogenic liposomes encapsulated with tetanus toxoid.
Tafaghodi M; Jaafari MR; Tabassi SA
Curr Drug Deliv; 2008 Apr; 5(2):108-13. PubMed ID: 18393812
[TBL] [Abstract][Full Text] [Related]
6. Impact of chitosan coating of anionic liposomes on clearance rate, mucosal and systemic immune responses following nasal administration in rabbits.
Amin M; Jaafari MR; Tafaghodi M
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):225-9. PubMed ID: 19699067
[TBL] [Abstract][Full Text] [Related]
7. Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit.
Mohaghegh M; Tafaghodi M
Pharm Dev Technol; 2011 Feb; 16(1):36-43. PubMed ID: 20082579
[TBL] [Abstract][Full Text] [Related]
8. Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid.
Pirouzmand H; Khameneh B; Tafaghodi M
Pharm Biol; 2017 Dec; 55(1):212-217. PubMed ID: 27927058
[TBL] [Abstract][Full Text] [Related]
9. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
10. Alginate microspheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis.
Tafaghodi M; Eskandari M; Khamesipour A; Jaafari MR
Exp Parasitol; 2011 Oct; 129(2):107-14. PubMed ID: 21767536
[TBL] [Abstract][Full Text] [Related]
11. Intranasal administration of CpG oligonucleotides induces mucosal and systemic Type 1 immune responses and adjuvant activity to porcine reproductive and respiratory syndrome killed virus vaccine in piglets in vivo.
Zhang L; Tian X; Zhou F
Int Immunopharmacol; 2007 Dec; 7(13):1732-40. PubMed ID: 17996683
[TBL] [Abstract][Full Text] [Related]
12. Induction of mucosal and systemic humoral immune responses in murine system by intranasal immunization with peptide antigens of P. vivax and CpG oligodeoxynucleotide (ODN) in microparticle delivery.
Bhat AA; Seth RK; Babu J; Biswas S; Rao DN
Int Immunopharmacol; 2009 Sep; 9(10):1197-208. PubMed ID: 19595793
[TBL] [Abstract][Full Text] [Related]
13. Intranasal vaccination of New Zealand white rabbits against pasteurellosis, using alginate-encapsulated Pasteurella multocida toxin and potassium thiocyanate extract.
Jarvinen LZ; HogenEsch H; Suckow MA; Bowersock TL
Comp Med; 2000 Jun; 50(3):263-9. PubMed ID: 10894489
[TBL] [Abstract][Full Text] [Related]
14. Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice.
Uppada SB; Bhat AA; Sah A; Donthamshetty RN
Vaccine; 2011 Nov; 29(50):9352-60. PubMed ID: 22001881
[TBL] [Abstract][Full Text] [Related]
15. IL-12 is an effective adjuvant for induction of mucosal immunity.
Boyaka PN; Marinaro M; Jackson RJ; Menon S; Kiyono H; Jirillo E; McGhee JR
J Immunol; 1999 Jan; 162(1):122-8. PubMed ID: 9886377
[TBL] [Abstract][Full Text] [Related]
16. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
Jaganathan KS; Vyas SP
Vaccine; 2006 May; 24(19):4201-11. PubMed ID: 16446012
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of nasal application of CpG oligodeoxynucleotide as a mucosal adjuvant.
Kodama S; Abe N; Hirano T; Suzuki M
Laryngoscope; 2006 Feb; 116(2):331-5. PubMed ID: 16467729
[TBL] [Abstract][Full Text] [Related]
18. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
Nyström-Asklin J; Adamsson J; Harandi AM
Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of mucosal immune responses by intranasal co-delivery of Newcastle disease vaccine plus CpG oligonucleotide in SPF chickens in vivo.
Zhang L; Zhang M; Li J; Cao T; Tian X; Zhou F
Res Vet Sci; 2008 Dec; 85(3):495-502. PubMed ID: 18359498
[TBL] [Abstract][Full Text] [Related]
20. Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx.
Abe N; Kodama S; Hirano T; Eto M; Suzuki M
Laryngoscope; 2006 Mar; 116(3):407-12. PubMed ID: 16540899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
